123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Business >> View Article

Regenerative Medicine Market - Industry Growth, Dynamics, Segmentation And Forecast

Profile Picture
By Author: robert
Total Articles: 430
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

MarketsandMarkets Research Report’s View on Revenue Impact?

The Global Regenerative Medicine Market is expected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.

Factors Responsible for Growth and In-Depth Analysis?

The Regenerative Medicine Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579

Leading Key Players and Analysis:

The major players operating in this market are 3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), ...
... Anterogen Co., Ltd. (South Korea), MiMedx Group (US), Misonix (US), Novartis AG (Switzerland), Organogenesis Inc. (US), Orthocell Limited (Australia), Corestem, Inc. (South Korea).

Novartis AG (Switzerland) is one of the the largest player in the regeneartive medicine market in 2019. In order to maintain its position in the market, the company has been focusing on the innovations, and breakthrough product approvals for the treatment of cancer. For instance, in August 2017, Novartis received the FDA approval for CAR-T cell therapy, Kymriah (CTL019), which is used for the treatment of cancer. Kymriah got the EU approval in August 2018. Novartis also focused on the inorganic strategies in order to enhance their dominance in the regenerative medicine market. For instance, Novartis received EU approval for one-time gene therapy, Luxturna, developed by Spark Therapeutics, to restore vision in people with rare and genetically-associated retinal disease.

Geographical Analysis in Detailed?

The regenerative medicine market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the market. The growth in the North American market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579

Industry Segmentation:

Tissue-engineered products segment accounted for the largest share of the regenerative medicine market.

Based on products, segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The tissue-engineered products segment accounted for the largest share in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Musculoskeletal segment accounted for largest share in the market.

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the musculoskeletal disorders segment accounted for the largest market share. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65442579

Total Views: 28Word Count: 543See All articles From Author

Add Comment

Business Articles

1. How To Apply For Family Visitor Visa?
Author: immigration solicitors

2. Services Is Expected To Remain The Largest Segment In The Global Pipeline Network Market
Author: Lucintel LLC

3. Pipeline & Process Service Market Is Anticipated To Grow At A Cagr Of 3%-5% During 2020-2025
Author: Lucintel LLC

4. Remortgage For Home Improvements Or Apply For A Loan
Author: Alicia Karan

5. Can You Remortgage With Bad Credit And How To Do It?
Author: Alicia Karan

6. How To Remortgage To Release Equity
Author: Alicia Karan

7. Importance Of Flame/fire Resistant Jackets
Author: tarasafe

8. Digital Light Processing Is Expected To Remain The Largest Segment In The Global Pico Projector Market
Author: Lucintel LLC

9. Why Do Couples Prefer Wooden Flowers Wedding?
Author: Abby Clare

10. Why Shop For Wood Flowers Wholesale
Author: Abby Clare

11. How To Decide Between Natural And Wood Flower Arrangements
Author: Abby Clare

12. Why Is The Wood Flower Bouquet An Alternative Worth Considering?
Author: Abby Clare

13. Why Are Bearings Important And Where To Buy The Bearings?
Author: rollerbearings

14. Why Do You Have To Buy From The Manufacturer's Service The Online?
Author: rollerbearings

15. What Are The Benefits That Are Gained By The Start-ups From The Gst Registration In Jaipur?
Author: Akash Kumar

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: